To measure and monitor the impact of coronavirus (COVID-19) on medical schemes and beneficiaries, the Council for Medical Schemes (CMS) requests medical schemes and exempted insurers providing indemnity products that are conducting the business of a medical scheme, to submit data for all cases of COVID-19. Beneficiaries suspected, diagnosed and treated for COVID-19 must be identified using the applicable ICD-10 code and the NICD case definition.